TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
AGEN

Agenus Inc

Healthcare · Biotechnology

7.20$ +0.1% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Agenus Inc (AGEN): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/09/2026.

Next report 11/09/2026
Last report 08/07/2026
Earnings surprise by quarter (%)
Q3 23 · 19.0 % 23 Q4 23 · -160.0 % 23 Q1 24 · 5.6 % 24 Q2 24 · -89.5 % 24 Q3 24 · -33.3 % 24 Q4 24 · 19.8 % 24 Q1 25 · 48.0 % 25 Q2 25 · -174.1 % 25 Q3 25 · -152.7 % 25 Q4 25 · 152.4 % 25 Q1 26 · -101.7 % 26 Q2 26 · -120.0 % 26

EPS estimate beaten

Full history 44 of 105 quarters (42%)
Last 16 quarters 5 of 16 quarters (31%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 08/18/2026 AGENUS INC (AGEN): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Unregistered Sales of Equity Securities · sec.gov Open ↗
  • 08/13/2026 AGENUS INC (AGEN): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Open ↗
  • 08/11/2026 AGENUS INC (AGEN): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Open ↗
  • 08/06/2026 AGENUS INC (AGEN): Results of Operations and Financial Condition · sec.gov Open ↗
  • 07/13/2026 AGENUS INC (AGEN): Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/06/2026 AGENUS INC (AGEN): Entry into a Material Definitive Agreement · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?